Company Information

Company Name
Hemanext
Company Description
Developer of a medical technology intended to support the transfusion medicine community in its efforts to save lives and improve patient outcomes. The company develops novel storage methods to potentially extend the shelf life of refrigerated red blood cells while improving quality across the storage cycle, enabling healthcare providers to promote improvements in the quality, safety, and efficacy and reduce the cost of transfusion therapy.
Industry Type
Hematology
Incoming Channel

Contact Information

CEO
Martin Cannon
COO
CFO
Eric Newman
CTO
CMO
Laurel Omert MD
CCO